You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Prolymphocytic

Showing 1 - 25 of 5,253
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

    Not yet recruiting
    • Leukemia, Acute
    • +7 more
    • (no location specified)
    Apr 10, 2023

    B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma Trial in Columbus (Letermovir)

    Recruiting
    • B-Cell Prolymphocytic Leukemia
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 18, 2022

    Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)

    Completed
    Has Results
    • Leukemia
    • +2 more
    • Boston, Massachusetts
    • +14 more
    Nov 23, 2022

    T-Prolymphocytic Leukemia Trial in Duarte, Columbus, Houston (APG-115, APG-2575)

    Recruiting
    • T-Prolymphocytic Leukemia
    • Duarte, California
    • +2 more
    Jul 8, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
    • +11 more
    Nov 23, 2022

    T-cell-prolymphocytic Leukemia Trial in Cologne (Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab, Alemtuzumab)

    Completed
    • T-cell-prolymphocytic Leukemia
    • Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
    • Alemtuzumab
    • Cologne, Germany
      University Hospital Cologne
    Dec 16, 2021

    Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +15 more
    • Anti-CD19/CD20/CD22 CAR T-Cells
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 4, 2022

    T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

    Not yet recruiting
    • T-Cell Non-Hodgkin Lymphoma
    • +14 more
    • WU-CART-007
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 17, 2023

    Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

    Recruiting
    • Cutaneous T-cell Lymphoma
    • +4 more
    • Columbus, Ohio
      The Ohio State University Cancer Center
    Apr 18, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Peripheral Blood Stem Cell Transplant
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Mar 27, 2023

    T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

    Completed
    Has Results
    • T-Cell Lymphoma Relapsed
    • +4 more
    • IL-15 plus
    • alemtuzumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 27, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023

    Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • +13 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Nov 2, 2022

    Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Active, not recruiting
    • Prolymphocytic Leukemia
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial in Columbus (acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Columbus, Ohio
      Research Site
    Mar 11, 2022

    Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

    Active, not recruiting
    • Contiguous Stage II Small Lymphocytic Lymphoma
    • +11 more
    • MOR00208
    • +2 more
    • Columbus, Ohio
      The Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +10 more
    • Jacksonville, Florida
    • +5 more
    Aug 14, 2023

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

    Active, not recruiting
    • Prolymphocytic Leukemia
    • +4 more
    • Columbus, Ohio
    • +1 more
    Apr 29, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

    Active, not recruiting
    • Acute Biphenotypic Leukemia
    • +18 more
    • Aurora, Colorado
    • +2 more
    Dec 28, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +16 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 1, 2022

    Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

    Recruiting
    • Acute Leukemia
    • +18 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 26, 2022

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

    Recruiting
    • Acute Leukemia
    • +24 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 4, 2021